While any promoter containing CRE sites would be targeted for ICER-associated inhibition of CREB promoted transcription, we chose BDNF promoters II and IV to study due to the connection between BDNF and neurodegenerative diseases. Here, CREB1 is linked to neurodegenerative disease.